{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:18:27Z","timestamp":1789773507435,"version":"4.0.1"},"reference-count":55,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":223,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"UT | University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["111411; 122322"],"award-info":[{"award-number":["111411; 122322"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160657; RP210088"],"award-info":[{"award-number":["RP160657; RP210088"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["CA016672-29"],"award-info":[{"award-number":["CA016672-29"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Triple-negative breast cancer (TNBC) has high relapse and metastasis rates and a high proportion of cancer stem-like cells (CSC), which possess self-renewal and tumor initiation capacity. MELK (maternal embryonic leucine zipper kinase), a protein kinase of the Snf1\/AMPK kinase family, is known to promote CSC maintenance and malignant transformation. However, the role of MELK in TNBC metastasis is unknown; we sought to address this in the current study. We found that MELK mRNA levels were higher in TNBC tumors [8.11 (3.79\u201310.95)] than in HR+HER2\u2212 tumors [6.54 (2.90\u20139.26)]; P &amp;lt; 0.001]. In univariate analysis, patients with breast cancer with high-MELK\u2013expressing tumors had worse overall survival (P &amp;lt; 0.001) and distant metastasis-free survival (P &amp;lt; 0.01) than patients with low-MELK\u2013expressing tumors. In a multicovariate Cox regression model, high MELK expression was associated with shorter overall survival after adjusting for other baseline risk factors. MELK knockdown using siRNA or MELK inhibition using the MELK inhibitor MELK-In-17 significantly reduced invasiveness, reversed epithelial-to-mesenchymal transition, and reduced CSC self-renewal and maintenance in TNBC cells. Nude mice injected with CRISPR MELK-knockout MDA-MB-231 cells exhibited suppression of lung metastasis and improved overall survival compared with mice injected with control cells (P &amp;lt; 0.05). Furthermore, MELK-In-17 suppressed 4T1 tumor growth in syngeneic BALB\/c mice (P &amp;lt; 0.001). Our findings indicate that MELK supports metastasis by promoting epithelial-to-mesenchymal transition and the CSC phenotype in TNBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>These findings indicate that MELK is a driver of aggressiveness and metastasis in TNBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0330","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T10:57:31Z","timestamp":1685530651000},"page":"1078-1092","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2294","authenticated-orcid":true,"given":"Xuemei","family":"Xie","sequence":"first","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"6Current Institution: Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9489-8361","authenticated-orcid":true,"given":"Gaurav B.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-6400","authenticated-orcid":true,"given":"Ramakrishna","family":"Edupuganti","sequence":"additional","affiliation":[{"name":"3Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3730-6591","authenticated-orcid":true,"given":"Takahiro","family":"Kogawa","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-7579","authenticated-orcid":true,"given":"Jihyun","family":"Park","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-1020","authenticated-orcid":true,"given":"Moises","family":"Tacam","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6972-570X","authenticated-orcid":true,"given":"Alex W.","family":"Tan","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-8135","authenticated-orcid":true,"given":"Mohd","family":"Mughees","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1436-0721","authenticated-orcid":true,"given":"Fnu","family":"Vidhu","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-0259","authenticated-orcid":true,"given":"Diane D.","family":"Liu","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-6445","authenticated-orcid":true,"given":"Juliana M.","family":"Taliaferro","sequence":"additional","affiliation":[{"name":"3Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7423-6072","authenticated-orcid":true,"given":"Mary Kathryn","family":"Pitner","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-321X","authenticated-orcid":true,"given":"Luke S.","family":"Browning","sequence":"additional","affiliation":[{"name":"3Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9281-7194","authenticated-orcid":true,"given":"Ju-Hyeon","family":"Lee","sequence":"additional","affiliation":[{"name":"3Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Bertucci","sequence":"additional","affiliation":[{"name":"5Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-7868","authenticated-orcid":true,"given":"Yu","family":"Shen","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-0673","authenticated-orcid":true,"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-7275","authenticated-orcid":true,"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"6Current Institution: Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-4136","authenticated-orcid":true,"given":"Savitri","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"7Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"8Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-4412","authenticated-orcid":true,"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5711-2404","authenticated-orcid":true,"given":"Debu","family":"Tripathy","sequence":"additional","affiliation":[{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-0040","authenticated-orcid":true,"given":"Steven J.","family":"Van Laere","sequence":"additional","affiliation":[{"name":"9Center for Oncological Research, Integrated Personalized and Precision Oncology Network, University of Antwerp, Antwerp, Wilrijk."},{"name":"10Department Oncology, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-4195","authenticated-orcid":true,"given":"Geoffrey","family":"Bartholomeusz","sequence":"additional","affiliation":[{"name":"11Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-5129","authenticated-orcid":true,"given":"Kevin N.","family":"Dalby","sequence":"additional","affiliation":[{"name":"3Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-1557","authenticated-orcid":true,"given":"Chandra","family":"Bartholomeusz","sequence":"additional","affiliation":[{"name":"1Section of Translational Breast Cancer Research, Houston, Texas."},{"name":"2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2024012907315903900_bib1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"2024012907315903900_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2024012907315903900_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"2024012907315903900_bib4","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"2024012907315903900_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00432-010-0957-x","article-title":"Characteristics of triple-negative breast cancer","volume":"137","author":"de Ruijter","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"2024012907315903900_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"2024012907315903900_bib7","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr1610","article-title":"CD44+\/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis","volume":"8","author":"Sheridan","year":"2006","journal-title":"Breast Cancer Res"},{"key":"2024012907315903900_bib8","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PLoS One"},{"key":"2024012907315903900_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","article-title":"Prevalence of CD44+\/CD24-\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis","volume":"11","author":"Abraham","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2024012907315903900_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5732\/cjc.011.10226","article-title":"Epithelial-mesenchymal transition in breast cancer progression and metastasis","volume":"30","author":"Wang","year":"2011","journal-title":"Chin J Cancer"},{"key":"2024012907315903900_bib11","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","article-title":"Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype","volume":"12","author":"Balic","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2024012907315903900_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2024012907315903900_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative breast cancer: disease entity or title of convenience?","volume":"7","author":"Carey","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"2024012907315903900_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"2024012907315903900_bib15","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1158\/0008-5472.CAN-04-4531","article-title":"Maternal embryonic leucine zipper kinase\/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers","volume":"65","author":"Gray","year":"2005","journal-title":"Cancer Res"},{"key":"2024012907315903900_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40169-014-0045-y","article-title":"MELK-a conserved kinase: functions, signaling, cancer, and controversy","volume":"4","author":"Ganguly","year":"2015","journal-title":"Clin Transl Med"},{"key":"2024012907315903900_bib17","doi-asserted-by":"crossref","first-page":"e01763","DOI":"10.7554\/eLife.01763","article-title":"MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells","volume":"3","author":"Wang","year":"2014","journal-title":"Elife"},{"key":"2024012907315903900_bib18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.18632\/oncotarget.790","article-title":"Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer","volume":"3","author":"Chung","year":"2012","journal-title":"Oncotarget"},{"key":"2024012907315903900_bib19","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr2350","article-title":"Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer","volume":"11","author":"Pickard","year":"2009","journal-title":"Breast Cancer Res"},{"key":"2024012907315903900_bib20","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/bcr1650","article-title":"Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family","volume":"9","author":"Lin","year":"2007","journal-title":"Breast Cancer Res"},{"key":"2024012907315903900_bib21","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1158\/1078-0432.CCR-15-2711","article-title":"Maternal embryonic leucine zipper kinase (MELK) as a novel mediator and biomarker of radioresistance in human breast cancer","volume":"22","author":"Speers","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2024012907315903900_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"2024012907315903900_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/bies.1132","article-title":"Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition","volume":"23","author":"Savagner","year":"2001","journal-title":"Bioessays"},{"key":"2024012907315903900_bib24","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","article-title":"Cancer drug resistance induced by EMT: novel therapeutic strategies","volume":"95","author":"De Las Rivas","year":"2021","journal-title":"Arch Toxicol"},{"key":"2024012907315903900_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","article-title":"Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype","volume":"68","author":"Sarrio","year":"2008","journal-title":"Cancer Res"},{"key":"2024012907315903900_bib26","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.bmc.2017.03.018","article-title":"Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth","volume":"25","author":"Edupuganti","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"2024012907315903900_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2144\/000112751","article-title":"Affymetrix whole-transcript human gene 1.0 ST array is highly concordant with standard 3' expression arrays","volume":"44","author":"Pradervand","year":"2008","journal-title":"Biotechniques"},{"key":"2024012907315903900_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1470-2045(07)70042-6","article-title":"Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study","volume":"8","author":"Gong","year":"2007","journal-title":"Lancet Oncol"},{"key":"2024012907315903900_bib29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/1078-0432.CCR-09-1456","article-title":"PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase","volume":"16","author":"Bartholomeusz","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2024012907315903900_bib30","doi-asserted-by":"crossref","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan blue exclusion test of cell viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr Protoc Immunol"},{"key":"2024012907315903900_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-1759(01)00347-7","article-title":"Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue","volume":"252","author":"Gloeckner","year":"2001","journal-title":"J Immunol Methods"},{"key":"2024012907315903900_bib32","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"2024012907315903900_bib33","doi-asserted-by":"crossref","first-page":"e2351","DOI":"10.21769\/BioProtoc.2351","article-title":"Soft agar colony formation assay as a hallmark of carcinogenesis","volume":"7","author":"Du","year":"2017","journal-title":"Bio Protoc"},{"key":"2024012907315903900_bib34","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/onc.2016.417","article-title":"c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun","volume":"36","author":"Xie","year":"2017","journal-title":"Oncogene"},{"key":"2024012907315903900_bib35","first-page":"881","article-title":"Molecular principles of cancer invasion and metastasis (review)","volume":"34","author":"Leber","year":"2009","journal-title":"Int J Oncol"},{"key":"2024012907315903900_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000337106","article-title":"Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells","volume":"79","author":"Ksiazkiewicz","year":"2012","journal-title":"Pathobiology"},{"key":"2024012907315903900_bib37","doi-asserted-by":"crossref","first-page":"e12180","DOI":"10.1371\/journal.pone.0012180","article-title":"Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells","volume":"5","author":"Klopp","year":"2010","journal-title":"PLoS One"},{"key":"2024012907315903900_bib38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/stem.1358","article-title":"MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells","volume":"31","author":"Joshi","year":"2013","journal-title":"Stem Cells"},{"key":"2024012907315903900_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14728222.2017.1363183","article-title":"MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies","volume":"21","author":"Pitner","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"2024012907315903900_bib40","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1074\/jbc.REV120.013433","article-title":"Enigmatic MELK: the controversy surrounding its complex role in cancer","volume":"295","author":"McDonald","year":"2020","journal-title":"J Biol Chem"},{"key":"2024012907315903900_bib41","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.18632\/oncotarget.23515","article-title":"MELK is a novel therapeutic target in high-risk neuroblastoma","volume":"9","author":"Guan","year":"2018","journal-title":"Oncotarget"},{"key":"2024012907315903900_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2016.09.017","article-title":"MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence","volume":"383","author":"Xia","year":"2016","journal-title":"Cancer Lett"},{"key":"2024012907315903900_bib43","doi-asserted-by":"crossref","first-page":"102609","DOI":"10.1016\/j.ebiom.2019.102609","article-title":"MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway","volume":"51","author":"Xu","year":"2020","journal-title":"EBioMedicine"},{"key":"2024012907315903900_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1535-7163.MCT-18-0819","article-title":"Maternal embryonic leucine zipper kinase (MELK), a potential therapeutic target for neuroblastoma","volume":"18","author":"Chlenski","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2024012907315903900_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ijc.23189","article-title":"Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas","volume":"122","author":"Marie","year":"2008","journal-title":"Int J Cancer"},{"key":"2024012907315903900_bib46","doi-asserted-by":"crossref","first-page":"e24179","DOI":"10.7554\/eLife.24179","article-title":"CRISPR\/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials","volume":"6","author":"Lin","year":"2017","journal-title":"Elife"},{"key":"2024012907315903900_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.isci.2018.10.015","article-title":"A Conditional dependency on MELK for the proliferation of triple-negative breast cancer cells","volume":"9","author":"Wang","year":"2018","journal-title":"iScience"},{"key":"2024012907315903900_bib48","doi-asserted-by":"crossref","first-page":"e26693","DOI":"10.7554\/eLife.26693","article-title":"MELK is not necessary for the proliferation of basal-like breast cancer cells","volume":"6","author":"Huang","year":"2017","journal-title":"Elife"},{"key":"2024012907315903900_bib49","doi-asserted-by":"crossref","first-page":"e32838","DOI":"10.7554\/eLife.32838","article-title":"MELK expression correlates with tumor mitotic activity but is not required for cancer growth","volume":"7","author":"Giuliano","year":"2018","journal-title":"Elife"},{"key":"2024012907315903900_bib50","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1074\/jbc.RA119.011083","article-title":"Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells","volume":"295","author":"McDonald","year":"2020","journal-title":"J Biol Chem"},{"key":"2024012907315903900_bib51","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1021\/bi4005864","article-title":"Structural insight into Maternal Embryonic Leucine zipper Kinase (MELK) conformation and inhibition towards structure-based drug design","volume":"52","author":"Canevari","year":"2013","journal-title":"Biochemistry"},{"key":"2024012907315903900_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2014.03.034","article-title":"The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor","volume":"447","author":"Cho","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2024012907315903900_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat Biotechnol"},{"key":"2024012907315903900_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2024012907315903900_bib55","first-page":"4421","article-title":"MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy","volume":"11","author":"Oshi","year":"2021","journal-title":"Am J Cancer Res"}],"updated-by":[{"DOI":"10.1158\/2767-9764.crc-24-0046","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000}}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0330\/3337616\/crc-22-0330.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/6\/1078\/3410931\/crc-22-0330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/6\/1078\/3410931\/crc-22-0330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:42:56Z","timestamp":1729510976000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/6\/1078\/727342\/Maternal-Embryonic-Leucine-Zipper-Kinase-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,20]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0330","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.23269404.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269407.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269401.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269395.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269395","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269404","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6673071.v3","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269398.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6673071.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269410","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269410.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6673071.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269398","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6673071","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269407","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.23269407","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545958","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269398","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545982.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545967.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545970","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545961.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545964.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545982","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545994","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545976.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545979.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545985","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269410","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545967.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545964.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545961","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545973","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545955.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545958.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545964","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269407.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545976","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545988","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269404.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545988.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269398.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269401.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269395.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545955.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545958.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545994.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545991.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545973.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545970.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545955","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545967","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545979","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269404","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545991","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545982.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545985.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545988.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269395","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545961.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545985.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545994.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545991.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545970.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23269410.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545979.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545973.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23545976.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]}}}